Antibody Discovery Services
In recent years, antibody-related therapies have made significant progress, ushering in a new era of medical breakthroughs for diseases, like leukemia. Under the leadership of pioneering research and innovative technology, scientists and experts from Alfa Cytology focus on antibody discovery services, bringing new hope to combat this devastating disease.
Overview of Antibody Discovery
Potential therapeutic antibodies can be quickly identified and their characteristics optimized through cutting-edge technologies, such as phage display, hybridoma technology, and next-generation sequencing. In addition, antibody discovery can promote the efficient production of therapeutic antibodies, ensuring their availability for preclinical testing and clinical trials. A highly specialized detection and screening platform helps identify antibodies with excellent binding affinity, selectivity and desired drug-like characteristics.
Fig. 1. The application of intracellular antibodies in discovery research, target validation, and novel therapies. (Rabbitts, T.H., 2023)
Through extensive screening and selection processes, antibody discovery services can recognize monoclonal antibodies that bind to antigens expressed on the surface of leukemia cells. These antibodies can accurately deliver targeted therapeutic drugs, such as chemotherapy drugs, toxins, or immune system activators, directly to cancer cells, thereby maximizing therapy efficacy while minimizing side effects on healthy tissues. Therefore, Alfa Cytology focuses on providing comprehensive antibody discovery services.
In Silico Antibody
Design
By harnessing the power of computational modeling and advanced algorithms, our services enable the rapid and cost-effective design of antibodies with enhanced functionality, specificity, and stability. Alfa Cytology provides tailored computer solutions for antibody design.
In Vitro Antibody
Screening
We do not need to use animals and can directly discover antibodies in the laboratory environment using recombinant DNA technology and various protein engineering techniques, such as phage display, mRNA display, and yeast surface display.
In Vivo Antibody
Discovery
We use mice, rabbits, or chickens to generate immune responses and produce target antibodies. Subsequently, antibodies were collected from the animal's body.
- Hybridoma technology
- B cell sorting
Why Choose Us?
Professional
Technical
Platform
Extensive
Development
Experience
Highly
Sophisticated
Scientists
Preferential
Prices
The use of advanced technology to discover highly targeted antibodies has brought new hope for improving efficacy and ultimately overcoming leukemia. The antibody discovery service provided by Alfa Cytology aims to usher in a personalized medical era and change the global risk of leukemia. Contact us immediately to discuss your project or inquire about our antibody discovery services. Our team is eager to collaborate and help you turn therapeutic innovation into reality.
Reference
- Rabbitts, T.H. Intracellular Antibodies for Drug Discovery and as Drugs of the Future. Antibodies 2023, 12, 24. https://doi.org/10.3390/antib12010024